Skip to main content
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Antreas Hindoyan
Sign up to set email alerts
85
Publications
873
Citation Statements Received
783
Citation Statements Given
How they've been cited
1,253
26
843
4
How they cite others
1,466
96
682
5
Affiliations
Amgen (United States)
,
University of Southern California
Publications
Order By: Most citations
Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Donahue
1
,
Tran
2
,
Hill
3
et al.
2012
Abstract
Show
222
6
167
2
Get access via publisher
Add to collection
Cite
An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells
Tsutsui
1
,
Valamehr
2
,
Hindoyan
3
et al.
2011
Nat Commun
Abstract
Show
162
3
156
1
Get access via publisher
Add to collection
Cite
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated
KRAS
G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Dy
1
,
Govindan
2
,
Velcheti
3
et al.
2023
JCO
Abstract
Show
168
5
78
0
Get access via publisher
Add to collection
Cite
Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells
Jiao
1
,
Hindoyan
2
,
Wang
3
et al.
2012
PLoS ONE
Abstract
Show
105
4
76
0
Get access via publisher
Add to collection
Cite
Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma
Gifford
1
,
Huang
2
,
Zeleniak
3
et al.
2016
Abstract
Show
106
1
80
0
Get access via publisher
Add to collection
Cite
Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML).
Ravandi
1
,
Walter
2
,
Subklewe
3
et al.
2020
JCO
Abstract
Show
107
1
59
0
Get access via publisher
Add to collection
Cite
Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE® (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Subklewe
1
,
Stein
2
,
Walter
3
et al.
2019
Abstract
Show
93
1
53
0
Get access via publisher
Add to collection
Cite
Largest evaluation of acquired resistance to sotorasib in
KRAS
p.G12C-mutated non–small cell lung cancer (NSCLC) and colorectal cancer (CRC): Plasma biomarker analysis of CodeBreaK100.
Li
1
,
Velcheti
2
,
Price
3
et al.
2022
JCO
Abstract
Show
29
1
22
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6
